Published date: 11 August 2020
This notice was replaced on 2 September 2020
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 2 September 2020)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Medical equipments, pharmaceuticals and personal care products - 33000000
Laboratory, optical and precision equipments (excl. glasses) - 38000000
Location of contract
NR4 7TJ
Value of contract
£100,000 to £125,000
Procurement reference
PURCON903 - TIPAL Spirometers
Published date
11 August 2020
Closing date
24 August 2020
Closing time
5pm
Contract start date
12 October 2020
Contract end date
12 October 2020
Contract type
Supply contract
Procedure type
Open procedure (below threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
The UEA Norwich Clinical Trials Unit (NCTU) is a UKCRC registered trials unit and works with sites and institutes across the UK to deliver high quality studies. The Norfolk and Norwich University Hospitals (NNUH) NHS Foundation Trust is the Sponsor for the TIPAL trial and will be a party to the contract under this tender. NNUH have delegated certain Sponsor activities including the provision of study supplies to UEA through NCTU including the procurement of domiciliary spirometers, smart phones or tablets and data platforms to collect spirometry data for the trial.
The Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL) trial is a National Institute for Health Research Health Technology Assessment programme funded clinical trial. The full trial title is: the effectiveness and risks of treating people with idiopathic pulmonary fibrosis with the addition of lansoprazole (TIPAL): a randomised, placebo-controlled multi-centre clinical trial. The trial aims to recruit 298 patients across 30 sites in the UK with recruitment anticipated to commence from Autumn 2020 following revisions to the initial study design due to the impact of the covid-19 pandemic.
All documents required as part of your tender response should be submitted via the appropriate area of the In-Tend e-tendering portal (link below) by the Tender Response Deadline, as set out in the Timescales section of the ITT.
https://in-tendhost.co.uk/universityofeastanglia/aspx/Home
About the buyer
Contact name
Sonny Gardiner
Address
Centrum
Norwich
NR47UG
England
Telephone
01603 597489
Share this notice